In a randomized, placebo-controlled trial of 207 premature infants with respiratory distress syndrome, we previously reported inhaled nitric oxide (iNO) decreased the incidence of chronic lung disease (CLD) and death (Schreiber et al., NEJM, 2003). The study also found that iNO decreased severe intraventricular hemorrhage/perventricular leukomalacia (IVH/PVL). To evaluate the long-term neurodevelopmental outcomes of these premature infants treated with iNO, we conducted a prospective follow-up of the original cohort (BW 983 378 g, GA 27.0 2.7 wks) to two years corrected age. The Bayley Scales of Infant Development and neurologic examinations were performed by examiners blinded to the original treatment assignment. Abnormal neurodevelopmental outcome was defined as having: A diagnosis of cerebral palsy, bilateral blindness or hearing loss, and/or an MDI or PDIϽ70. A total of 138 infants (82% of survivors) were followed. Compared with placebo-treated infants, patients treated with iNO had a significantly lower risk of an abnormal neurodevelopmental outcome (relative risk 0.53; 95% confidence interval, 0.33-0.87; Pϭ0.01). After adjustment for CLD, the risk of abnormal outcome was still significantly reduced in the iNO group (relative risk, 0.59; 95% confidence interval, 0.36 -0.95; Pϭ0.03). Similarly, the risk remained reduced even after adjustment for severe IVH/PVL (relative risk, 0.55; 95% confidence interval 0.34 -0.89; Pϭ0.01). The iNO group had approximately one half the risk of cognitive impairment (MDIϽ70) and/or psychomotor impairment (PDIϽ70) compared with the placebo group (relative risk, 0.55; 95% confidence interval, 0.33-0.93; Pϭ0.03). This difference was due primarily to a decrease in cognitive impairment in the iNO group (relative risk, 0.53; 95% confidence interval, 0.29 -0.94; Pϭ0.03) but not in psychomotor impairment (relative risk, 0.73; 95% confidence interval, 0.33-1.61; Pϭ0.48). In conclusion, premature infants treated with iNO in the first week of life had a significantly lower risk of having an abnormal neurodevelopmental outcome at two years of age.
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LONG-TERM CONTINUOUS EEG-MONITORING IN VERY PREMATURE CHILDREN EM SCHUMACHER, H SJOHOLM, T STIRIS 1 DEPTS OF PAEDIATRICS -NICU AND CLINICAL NEUROPHYSIOLOGY, ULLEVAL UNIVERSITY HOSPITAL (NORWAY)
Background: The immature brain is vulnerable for insults the first days of life. It is desirable to have a method for continuous monitoring of the brain in this critical period of time. Unfortunately, available methods like time-compressed amplitude integrated EEG based on only few channels, have definite limitations.
Objective: To devise a method for stable continuous long-term EEG monitoring covering both hemispheres of the brain.
Methods: After consent from the parents and approval from the Ethics Committee thirty premature babies below 30 weeks of gestational age were included within twelve hours after birth. We used a digital EEG system ( NERVUS a/S ) for continuous EEG monitoring during their first three days of life. 10 electrodes were symmetrically placed over both hemispheres leaving space over vertex for ultrasound measurements to be made when needed.
Results: Out of 30 patients we succeeded to perform full-length (72 hours) recordings in 28 cases. Successful recordings were characterized by stable electrode contacts with impedances within the normal range which were repeatedly checked every third hour. There were no apparent signs that the scalp electrodes disturbed the patients. Digital recordings make it possible to quantify general and focal changes in the brain as well as seizure activity.The predictive value of the EEG changes for later outcome will be established when we compare early EEG patterns to the patients' status at 2 years of age.
Conclusions: We have demonstrated that it is feasible to perform long-term continuous EEG monitoring in very premature children. This should be of importance in order to detect general or focal brain dysfunction where rapid intervention is advantageous.
TROPONIN SERUM LEVELS AND ECHOCARDIOGRAPHIC LEFT VEN-TRICULAR EVALUATION IN PRETERM NEWBORNS WITH RESPIRA-TORY DISTRESS SYNDROME C MATTIA, P SCIACCA, P. BETTA, M.G. ROMEO, G. DISTEFANO 1 UNIT OF PEDIATRIC CARDIOLOGY -DEPARTMENT OF PEDIATRICS , 2 UNIT OF PEDIATRIC CARDIOLOGY -DEPARTMENT OF PEDIATRICS, 3 NICU -DEPARTMENT OF PEDIATRICS, 4 NICU -DEPART-MENT OF PEDIATRICS, 5 U. OF NEONATAL PATHOLOGY (ITALY) Backgrounds:
Perinatal asphyxia is frequently associated with heart impairment. In this study we related troponin serum levels (a cardiac ischaemic index in adults) with left ventricle B-mode functional evaluation in preterm infants with RDS Methods: We studied 40 hypoxaemic preterm newborns affected by RDS, with gestational age ranging 26 -34 w. and weight ranging 890-2400 gr. In all newborns pH, PaCO2, PaO2, HCO3, ABE, SBE, Heart rate, MAP, SaO2 and thoracic radiography, were evaluated at admission to the NICU of University of Catania. Infants were divided in 2 groups: the first with mean pH 7,17 ϩ-0,05 and serious RDS needing IPPV (16 patients); the second with mean pH 7,27 ϩ-0,03 and mild RDS not requiring IPPV (24 patients).
Troponin determination was made 12 h after birth together with left ventricle echocardiography evaluation. End diastolic volume, End sistolic volume, Stroke volume (SV), cardiac output (CO) and Ejection Franction (EF) were studied by using B-mode ellipsoidal method.
Results: Mean serum levels of Troponin were significantly higher in the first group with severe RDS (0,26 ϩ-0,161 mcg/ml) than in the second with mild RDS (0,037 ϩ-0,0031 mcg/ml). We demonstrated a significant inverse correlation between Troponin levels and left ventricular functional index that were lower in the first group (SV 0,49ϩ-12 ml/b; CO 52,5 ϩ-14 ml/min; EF 46 ϩ-10%) than in the second (SV 1,14 ϩ-32 ml/b; CO 131,5 ϩ-34 ml/min; EF 59,2 ϩ-8%) . It had been necessary adding inotropic therapy with Dopamine and Dobutamine in 12 patients of the first group.
Conclusions: These results suggest that elevated Troponin levels in preterm newborns are related both with hypoxic insult and with cardiac dysfunction. Troponin levels such as echocardiographic b-mode left ventricular evaluation can be helpful to objectively check myocardial function in preterm infants with RDS in order to early recognise heart impairment evaluating the correct use of inotropic therapy. Unfortunately, the increase in twin and higher-order gestations has also increased maternal and perinatal risks. Data from recent literature try to point-out differences in obstetric and neonatal outcomes in spontaneus multiple pregnancies versus pregnancies obtained with OS or assisted procreation. The aim of this study is to evaluate and compare spontaneous vs non-spontaneous neonatal outcomes of triplet pregnancies in the Policlinic A. Gemelli, a reference centre for high risk pregnancies.
NEONATAL OUTCOME IN TRIPLET PREGNANCIES
Methods We studied 24 triplet pregnancies, 6 spontaneous, 7 obtained with OI and 11 obtained with assisted procreation techniques. All 72 newborns were evaluated for: prematurity, neonatal weight, IUGR, birth weight discordance, need for resuscitation at birth, and major neonatal diseases (infective, hematologic, respiratory, cardiovascular, malformative and neurologic).
Results Spontaneous and non-spontaneous triplet pregnancies had similar EG and neonatal weight: EG 33Ϯ1 weeks vs 33Ϯ2 weeks, neonatal weight 1705Ϯ256 g vs 1907Ϯ452. There were no significative differences in IUGR and birth weight discordance (Ͼ20%) and in major neonatal diseases. Among non-spontaneous triplets we observed 2 malformative diseases (a polimalformative syndrome and a cri-du-chat syndrome), 2 neurologic diseases (IVH 2 grade), 1 cardiovascular disease (surgically treated PDA) and 1 feto-fetal transfusion.
Conclusions Our results confirm literature data about absence of significative neonatal outcome differences between spontaneous and non-spontaneous triplet pregnancies, but individual clinics and collaborative efforts are needed to extend the number of observations about major neonatal diseases (expecially malformative). 
THE UTILITY OF TWO-CHANNEL BEDSIDE EEG MONITORING IN TERM BORN ENCEPHALOPATHIC INFANTS IN RELATION TO CEREBRAL IN-JURY AS DEFINED BY MR IMAGING

MUR-DOCH CHILDRENS RESEARCH INSTITUTE (AUSTRIA), 2 ROYAL CHILDREN'S AND ROYAL WOMEN'S HOSPITALS (AUSTRIA), 3 VICTORIA INFANT BRAIN STUDY (AUSTRIA)
Objective: Single channel amplitude-integrated EEG has been shown to be predictive of neurodevelopmental outcome in term infants with hypoxic-ischemic encephalopathy (HIE). We describe the relationship of quantifiable EEG measures, obtained using a two-channel digital bedside EEG monitor, from term newborn infants with encephalopathy and/or seizures to cerebral injury defined qualitatively by MR imaging and also the effect of anticonvulsants on these measures.
Methods: Median values of minimum, mean and maximum EEG amplitude were obtained from 95 term-born encephalopathic infants during a two hour seizure-free period obtained within 72 hours of admission. Ninety-three infants underwent MR imaging with images qualitatively scored for abnormalities of cortex, white matter, deep nuclear grey matter and posterior limb of internal capsule. For seven infants, EEG measures obtained immediately prior to and half an hour after anticonvulsant were compared.
Results: For all infants there was a direct relationship between EEG amplitude measures and MR abnormality scores (MRAS). This relationship was strongest for the minimum amplitude measures (nϭ86, left; SE 0.13, pϽ0.001) . This relationship persisted on sub-group analysis for infants with HIE (nϭ47, left; bϭ-1.06, SE 0.19, pϽ0.001) and after adjusting for the use of anticonvulsants. Using a MRAS cut-off of 7, a minimum amplitude of 4 mcV showed a higher specificity (85%) whereas a minimum amplitude of 6 mcV showed a higher sensitivity (77%). Anticonvulsant administration produced a mean reduction in minimum amplitude of 0.9 mcV. Infants with higher minimum amplitudes prior to anticonvulsant administration showed a larger drop in amplitude after administration.
Conclusion: Bedside EEG measures in term-born encephalopathic infants are related to the severity of cerebral injury as defined by qualitative MRimaging. A minimum amplitude of 4 mcV appears useful in predicting outcome whereas 6 mcV may be more useful for screening purposes, such as the enrollment criterion for neuro-protective interventions. Objective: To assess the relationship of the apparent diffusion coefficient (ADC), from diffusion MR imaging, to the severity of white matter injury and maturation in fixed tissue from a baboon model of premature birth Methods: Thirty-one baboons were delivered at 125 d gestational age (GA, equivalent to 28 weeks GA in the human) and were sacrificed between 139 and 160 d post-conceptional age (PCA). Support included surfactant, ventilator support, inotropic support, TPN, and physiological monitoring. Following sacrifice, the brains were immersion fixed in 10% formalin. Control data were obtained from 9 animals sacrificed immediately after delivery, from 90 to 160 d. MR data were obtained using a 4.7-T system and DTIs generated using a 2D spin echo pulse sequence. ADC values were analyzed as pairs in the frontal, central, and occipital areas. Forebrain sections were stained with H,E and glial fibrillary acidic protein to assess cerebral injury and gliosis. A white matter abnormality score (WMAS) was formulated using the presence of ventriculomegaly, areas of axonal damage, white matter gliosis and GFAP immunoreactivity in radial glial fibers. Damage was scored throughout the rostral-caudal extent of the brain; scale 0 (no abnormality) to 22 (severe abnormality).
CORRELATION BETWEEN WATER DIFFUSION VALUES AND HIS-TOPATHOLOGICAL WHITE MATTER CHANGES IN FIXED TISSUE FROM A PRIMATE MODEL OF PREMATURE BIRTH
Results: On linear regression there was a direct relationship between the mean ADC and the PCA within the gestational control group (bϭ-0.001, pϭ0.01). There was also a direct relationship between ADC and WMAS for each region, which persisted when adjusted for PCA (bϭ 0.03, p Ͻ 0.01 central region).
Conclusions: The association of white matter gliosis and axonal damage with elevated ADC values supports the hypothesis that elevated ADC values, as described in premature infants, reflect white matter injury with associated alterations in white matter microstructure.
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